Portrait der Abbvie Aktie
Das Unternehmen Abbvie aus USA ist in den Bereichen Chemie & Pharma, Biotechnologie & Pharmazeutika, Biotechnologie, Pharma tätig.
Abbvie ist in mehr als 87 ETFs enthalten und somit ein eher allgemein bekannter Wert. Der Spitzenreiter First Trust Morningstar Dividend Leaders ETF (CAD-Hedged) gewichtet Abbvie mit 7,03% im ETF.
Es ist auch möglich über Anleihen zu investieren. Hier findest du alle Abbvie Anleihen auf einen Blick.
Entdecke die 6 ETFs in denen Abbvie am höchsten gewichtet ist Insgesamt in 87 ETFs enthalten
Dir gefallen die Informationen zu Abbvie?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu Abbvie?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu Abbvie?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu Abbvie?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
324 News & Informationen zur Abbvie Aktie
AbbVie Stock: Strong Earnings Make Bull Case For Undervalued Pharma (NYSE:ABBV)
AbbVie’s Q1 and Q2 2021 earnings results hint at a well executed growth strategy. Check out why I believe a >20% growth in ABBV stock is reasonable.
Were Hedge Funds Right About AbbVie Inc (ABBV)?
The Insider Monkey team has completed processing the quarterly 13F filings for the March quarter submitted by the hedge funds and other money managers included in our extensive database.
Were Hedge Funds Right About Pfizer Inc. (PFE)?
The 800+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the first quarter, which unveil their equity positions as of March 31st…
Were Hedge Funds Right About Merck & Co., Inc. (MRK)?
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 900 active prominent money managers and analyze their…
AbbVie Stock: Undervalued Dividend Stock, Huge Pipeline Of Possibilities (NYSE:ABBV)
AbbVie beat Q2 estimates and it has an impressive pipeline of treatments. Read why I was disappointed for not investing in ABBV stock when it was under $100.
SKYRIZI® (risankizumab-rzaa) Now Available in the U.S. as a Single 150 mg Injection for Adults with Moderate to Severe Plaque Psoriasis
NORTH CHICAGO, Ill., Aug. 9, 2021 /PRNewswire/ — AbbVie (NYSE: ABBV) today announced that SKYRIZI® (risankizumab-rzaa), an interleukin-23 (IL-23)…
3 more House reps have broken the law by failing to properly disclose their financial trades
Reps. Steve Chabot, a Republican from Ohio; Cheri Bustos, a Democrat from Illinois; and August Pfluger, a Republican from Texas. Tom Williams/CQ…
Molecular Partners To Regain Global Rights To Abicipar
Global rights to registrational-stage ophthalmology drug return to Molecular Partners
Improvements in manufacturing and formulation have been made and
Molecular Partners to Regain Global Rights to Abicipar
Global rights to registrational-stage ophthalmology drug return to Molecular PartnersImprovements in manufacturing and formulation have been made and…
AbbVie: Diversified Strength Tempers The Humira Patent Cliff Ahead (NYSE:ABBV)
AbbVie's diversified & strong collection of products will temper the 2023 Humira patent cliff that could decline revenues by $9B.
AbbVie Stock: Similar To Equity Bond With 12.5% Yield (NYSE:ABBV)
This article analyses AbbVie stock under the framework of perpetual growth and Buffett’s 10x Pretax Rule. Check out the returns on ABBV stock in the long term.
AbbVie: Continued Performance (NYSE:ABBV)
AbbVie and Allergan combination is doing much better than anticipated, boosting earnings power and reducing leverage. See more about the stock's valuation and my recommendation.
AbbVie vs.Teva: Which Drug Manufacturing Stock is a Better Choice? By StockNews
AbbVie vs.Teva: Which Drug Manufacturing Stock is a Better Choice?
10 Biotech Penny Stocks to Buy According to Reddit
In this article, we discuss the 10 biotech penny stocks to buy according to Reddit.
Global $191 Billion Orphan Drugs Markets To 2026: Therapeutic Applications In Rare And Orphan Diseases, Regulatory Framework, Patents, And Innovations
DUBLIN, Aug. 5, 2021 /PRNewswire/ — The
Global Cancer Therapies Market to Reach $204.2 Billion by 2024
/PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled…
Diversified Portfolios, Inc. Buys Altair Engineering Inc, Vanguard ESG U.S. Stock ETF, Vanguard ESG International Stock ETF, Sells Vanguard Short-Term Bond ETF, Vanguard Intermediate-Term Bond ETF, Sh
GuruFocus Article or News written by insider and the topic is about:
Global Meibomian Gland Dysfunction Treatment Market Size to Grow at a CAGR of 9.2% from 2021 to 2030
The Global Meibomian Gland Dysfunction Treatment Market has been estimated to reach a value of USD 158.6 billion in 2021 and is projected to grow at a CAGR…
Global Meibomian Gland Dysfunction Treatment Market Size to Grow at a CAGR of 9.2% from 2021 to 2030
The Global Meibomian Gland Dysfunction Treatment Market has been estimated to reach a value of USD 158.6 billion in 2021 and is projected to grow at a CAGR…
Global Meibomian Gland Dysfunction Treatment Market Size to Grow at a CAGR of 9.2% from 2021 to 2030
The Global Meibomian Gland Dysfunction Treatment Market has been estimated to reach a value of USD 158.6 billion in 2021 and is projected to grow at a CAGR…
Global Meibomian Gland Dysfunction Treatment Market Size to Grow at a CAGR of 9.2% from 2021 to 2030
The Global Meibomian Gland Dysfunction Treatment Market has been estimated to reach a value of USD 158.6 billion in 2021 and is projected to grow at a CAGR…
Global Meibomian Gland Dysfunction Treatment Market Size to Grow at a CAGR of 9.2% from 2021 to 2030
The Global Meibomian Gland Dysfunction Treatment Market has been estimated to reach a value of USD 158.6 billion in 2021 and is projected to grow at a CAGR…
Global Meibomian Gland Dysfunction Treatment Market Size to Grow at a CAGR of 9.2% from 2021 to 2030
The Global Meibomian Gland Dysfunction Treatment Market has been estimated to reach a value of USD 158.6 billion in 2021 and is projected to grow at a CAGR…
Takeda Receives Decision By The Irish Tax Appeals Commission Relating To Tax Assessment On Break Fee Shire Received From AbbVie
Takeda Pharmaceutical Company Limited ( TSE:4502/NYSE:TAK)(“Takeda”) today announced the receipt of a decision by the Irish Tax Appeals Commission on July 30,
Abbvie Stock: Still Undervalued With More Room To Grow (NYSE:ABBV)
Abbvie looks like a great opportunity for dividend investors today, offering a 4.5% yield with 49 consecutive years of dividend growth. The stock appears undervalued compared to future FCF.
Groesbeck Investment Management Corp Buys M.D.C. Holdings Inc, Nexstar Media Group Inc, BlackRock Inc, Sells Sherwin-Williams Co, 3M Co, Vertex Pharmaceuticals Inc
GuruFocus Article or News written by insider and the topic is about:
Distillate Capital Partners LLC Buys Facebook Inc, AbbVie Inc, Apple Inc, Sells Walmart Inc, Applied Materials Inc, Anthem Inc
GuruFocus Article or News written by insider and the topic is about:
AbbVie Inc. (ABBV) CEO Rick Gonzalez on Q2 2021 Results – Earnings Call Transcript
AbbVie Inc. (NYSE:ABBV) Q2 2021 Earnings Conference Call July 30, 2021, 09:00 AM ET Company Participants Liz Shea – VP of IR Rick Gonzalez – Chairman of the Board and CEO Jeff Stewart – EVP…
AbbVie to advance beta-amyloid Alzheimer's candidate, abandon (NYSE:ABBV)
AbbVie has decided to advance a candidate that will target beta-amyloid plaque in the brain as an Alzheimer's treatment, while abandoning ABBV-8E12, a phase 2 asset that targets tau.
Have $500? Here Are 2 High-Yielding Healthcare Stocks to Consider
These two companies offer impressive — and safe — yields for investors who like income.
AbbVie Inc. (ABBV) Reports Second-Quarter 2021 Financial Results
AbbVie cites growth of immunology business in the second quarter
AbbVie Inc. undefined beat expectations for the second quarter of 2021, driven largely by gains in its immunology business. The drug maker had earnings of…
AbbVie tops Q2 forecast; non-GAAP EPS outlook for FY21 raised (NYSE:ABBV)
AbbVie (ABBV) reports financial results for Q2 ended June 30, 2021, which came in ahead of analyst expectations.Worldwide net revenues were $13.96B, an increase of 33.9% over Q2…
AbbVie raises annual profit forecast as Botox demand rebounds
Breaking News, Latest News and Current News from OANN.com. Breaking news and video. Latest Current News: U.S., World, Entertainment, Health, Business, Technology, Politics, Sports.
AbbVie raises annual profit forecast as Botox demand rebounds By Reuters
AbbVie raises annual profit forecast as Botox demand rebounds
AbbVie Inc. Stock Quote (U.S.: NYSE)
ABBV | Complete AbbVie Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Nasdaq Futures 150 Pts Lower; Amazon, Pinterest Results Drag By Investing.com
Nasdaq Futures 150 Pts Lower; Amazon, Pinterest Results Drag
Earnings Scheduled For July 30, 2021
Companies Reporting Before The Bell
• Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its second quarter.
• …
Suncoast Equity Management Buys Edwards Lifesciences Corp, Steris PLC, AbbVie Inc, Sells Check Point Software Technologies
GuruFocus Article or News written by insider and the topic is about:
Oak Family Advisors, Llc Buys Northrop Grumman Corp, Vanguard Short-Term Inflation-Protected Securities, B2Gold Corp, Sells Weyerhaeuser Co, Dominion Energy Inc, Pfizer Inc
GuruFocus Article or News written by insider and the topic is about: